Diabetes and Pregnancy

Preconception Preparation for Diabetes Patients

For women with existing diabetes, thorough preparation before pregnancy is key to ensuring maternal and fetal safety. Preconception consultation should include blood glucose control assessment, medication adjustment, complication screening, and nutritional counseling.

Blood glucose control is the core of preconception preparation. Good blood glucose control can significantly reduce risks of fetal malformations and miscarriage. It is recommended to keep hemoglobin A1c (HbA1c) below 6.5% for 3-6 months before pregnancy. If HbA1c exceeds 8%, pregnancy should be delayed while strengthening blood glucose control.

Medication adjustment before pregnancy is also important. Certain oral glucose-lowering drugs are not safe during pregnancy and need to be switched to insulin therapy. For example, the safety of metformin during pregnancy is controversial—it should be discussed with a doctor before pregnancy whether to continue use. For patients using insulin, insulin type and dosage may need adjustment before pregnancy.

Complication screening should be performed before pregnancy. Complications that diabetes may cause include retinopathy, nephropathy, cardiovascular disease, etc., which may worsen during pregnancy. Comprehensive complication assessment should be performed before pregnancy, including fundus examination, urine microalbumin detection, blood pressure monitoring, etc.

Preconception Examination

Blood Glucose Control Targets During Pregnancy

Blood glucose management requirements during pregnancy are stricter than in non-pregnant states, as elevated blood glucose increases risks of fetal malformations, macrosomia, preterm birth, etc. ADA-recommended blood glucose control targets during pregnancy are: fasting blood glucose 3.3-5.3 mmol/L, 1-hour postprandial blood glucose <7.8 mmol/L, 2-hour postprandial blood glucose <6.7 mmol/L.

HbA1c should also be controlled within stricter ranges during pregnancy. For most pregnant diabetes patients, HbA1c control target is <6% (if achievable without causing hypoglycemia), but can be relaxed to <7% if hypoglycemia risk exists. HbA1c should be tested every 1-2 months during pregnancy.

Blood glucose monitoring frequency during pregnancy should be based on blood glucose control status and treatment regimen. Patients using insulin therapy typically need to monitor blood glucose 4-7 times daily, including fasting, pre-meal, and post-meal. Patients using continuous glucose monitoring (CGM) can obtain more comprehensive blood glucose data to help adjust treatment.

Nutritional Management During Pregnancy

Nutritional management during pregnancy is another important component of diabetes patient management during pregnancy. Nutritional requirements during pregnancy differ from non-pregnant states—sufficient nutritional intake to support fetal development needs to be ensured while controlling blood glucose.

Carbohydrate intake during pregnancy should account for 45-55% of total energy, choosing low-glycemic-index foods such as whole grains, legumes, vegetables, and fruits. Protein intake should account for 15-20% of total energy, prioritizing high-quality proteins such as lean meat, fish, eggs, and legumes. Fat intake should account for 25-35% of total energy, prioritizing unsaturated fatty acids.

Gestational weight gain should be individualized based on pre-pregnancy BMI. For women with normal pre-pregnancy weight, recommended weight gain during entire pregnancy is 11.5-16 kg. For overweight women, recommended gain is 7-11.5 kg. For obese women, recommended gain is 5-9 kg. Excessive or insufficient gestational weight gain increases risks of adverse pregnancy outcomes.

Fetal Monitoring and Delivery

Diabetes patients require more frequent fetal monitoring during pregnancy. Ultrasound examination can assess fetal growth, amniotic fluid volume, and placental function. Fetal heart monitoring should be performed in late pregnancy to assess fetal intrauterine condition.

Regarding delivery timing, for type 1 or type 2 diabetes patients with good blood glucose control and no complications, induction at 39-40 weeks is possible. For patients with poor blood glucose control or complications, earlier delivery may be needed.

Delivery method should be comprehensively decided based on fetal size, fetal position, and maternal condition. Diabetes itself is not a cesarean section indication. However, when estimated fetal weight ≥4000g or ≥4500g, elective cesarean section can be considered. During vaginal delivery, continuous electronic fetal monitoring should be maintained, with attention to blood glucose monitoring.

Frequently Asked Questions

Q1: Can diabetes patients have normal pregnancies?

Of course, as long as thorough preparation is made before pregnancy and blood glucose is well controlled, safe pregnancy is possible. The key is preconception consultation and assessment, plus good blood glucose management during pregnancy.

Q2: Is insulin use safe during pregnancy?

Insulin is the recommended medication for blood glucose control during pregnancy. Insulin does not cross the placenta and is safe for the fetus. Various types of insulin can be used during pregnancy, including short-acting insulin, intermediate-acting insulin, and insulin analogues.

Q3: Will diabetes be passed to children?

Diabetes does have a genetic predisposition, but genetics only accounts for part of the disease development. Acquired factors (such as lifestyle) play a more important role in diabetes development. There is no need to overly worry that children will definitely develop diabetes, but cultivating healthy lifestyle habits from childhood is important.

This content is for reference only and cannot replace professional medical advice. For health concerns, please consult your doctor.